CN105362452A - Medicine for treating Raynaud disease - Google Patents

Medicine for treating Raynaud disease Download PDF

Info

Publication number
CN105362452A
CN105362452A CN201410431053.9A CN201410431053A CN105362452A CN 105362452 A CN105362452 A CN 105362452A CN 201410431053 A CN201410431053 A CN 201410431053A CN 105362452 A CN105362452 A CN 105362452A
Authority
CN
China
Prior art keywords
parts
radix
medicine
raynaud disease
preparata
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201410431053.9A
Other languages
Chinese (zh)
Inventor
李敏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410431053.9A priority Critical patent/CN105362452A/en
Publication of CN105362452A publication Critical patent/CN105362452A/en
Withdrawn legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicine for treating the Raynaud disease. The medicine is prepared from, by weight, 4-8 parts of cassia twigs, 8-12 parts of radix astragali preparata, 10-20 parts of radix angelica sinensis, 9-15 parts of fried white peony roots, 4-8 parts of rhizoma chuanxiong, 8-12 parts of radix rehmanniae preparata, 4-8 parts of radix liquiritiae, 9-15 parts of common clubmoss herb, 15-25 parts of spatholobus suberctu and 9-15 parts of radix cyathulae. According to the medicine for treating the Raynaud disease, the ten kinds of natural traditional Chinese medicine are selected for compatibility, the raw materials act cooperatively to achieve the functions of cooling blood for detoxification, tonifying qi and lifting yang, promoting blood and qi circulation, invigorating qi and nourishing yin, activating yang and restoring the pulse, dispelling wind and relieving pain, replenishing essence and benefiting marrow, relaxing tendon and activating collaterals and the like, causes and symptoms are treated at the same time, the Raynaud disease treatment effect is good, and toxic and side effects are avoided. Besides, a preparation method of the medicine is simple, a treatment course is short, the medicine is convenient to take, cost is low, and the effective rate is 90% or above.

Description

A kind of medicine for the treatment of Raynaud disease
Technical field
The present invention relates to Chinese medicine, specifically a kind of medicine for the treatment of Raynaud disease.
Background technology
Raynaud disease generally refers to Raynaud syndrome, is also called Raynaud's disease.Raynaud syndrome is due to cold or excitedly cause pale, the blue one group of syndrome then becoming flushing of paroxysmal finger (toes).During outbreak, brothers are cold, numb, occasionally have pain.During Typical onset, take metacarpophalangeal joints as boundary, finger sent out cool, pale, blue, flushing then.Terminal stage of a disease, engender that dorsal surfaces of fingers fine hair disappears, nail growth be slack-off, coarse, distortion, atrophoderma is thinning and feel nervous (scleroderma refers to), forms ulcer around finger tip or nail matrix, and can cause infection.
The traditional Chinese medical science think blood stasis due to qi deficiency, yang deficiency tremble with fear contain for morbidity principal element, and emotional stimulation and cold-evil take advantage of attack into morbidity essential condition.Because qi being the governor of blood, the capable then blood of gas, deficiency of vital energy hematogenous blockage and being retarded by silt, blood stasis venation then sends out primary disease; Innate deficiency of YANG in the body, cold from interior life, cold Sheng then blood clotting is puckery, thrombosis and falling ill; Emotional stimulation causes human body depression of liver-QI, imbalance of YIN and YANG, disharmony between QI and blood, meridian and vessels obstruction, and function is disorderly, wherein with disgruntled be, disgruntled is YIN pathogen, cold-evil's excessive meridians outward, makes blood clotting puckery and does not flow, inside and outside combined pathogens, then venation qi and blood stagnation and falling ill.Primary disease is the card of deficiency in origin and excess in superficiality, and the deficiency of vital energy, yang deficiency are this, and the stagnation of QI, blood stasis are mark.
Summary of the invention
The medicine of the treatment Raynaud disease the object of this invention is to provide a kind of good effect, the course for the treatment of is shorter, cost is low, having no side effect.
The technical scheme realizing the object of the invention is:
Treating a medicine for Raynaud disease, is be made up of the raw material of following weight proportioning:
Ramulus Cinnamomi 4-8 part, Radix Astragali Preparata 8-12 part, Radix Angelicae Sinensis 10-20 part, Radix Paeoniae Alba (parched) 9-15 part, Rhizoma Chuanxiong 4-8 part, Radix Rehmanniae Preparata 8-12 part, Radix Glycyrrhizae Preparata 4-8 part, Herba Lycopodii 9-15 part, Caulis Spatholobi 15-25 part, Radix Cyathulae 9-15 part.
Preferably, the optimum weight proportioning of each raw material is:
Ramulus Cinnamomi 6 parts, Radix Astragali Preparata 10 parts, Radix Angelicae Sinensis 15 parts, Radix Paeoniae Alba (parched) 12 parts, Rhizoma Chuanxiong 6 parts, 10 parts, Radix Rehmanniae Preparata, Radix Glycyrrhizae Preparata 6 parts, Herba Lycopodii 12 parts, Caulis Spatholobi 20 parts, Radix Cyathulae 12 parts.
Described crude drug is in shop of Chinese medicines and commercially available.
The preparation method of medicine of the present invention, can decoct into decoction according to a conventional method, and concrete grammar is: take each crude drug by weight ratio, adds the water of 5-10 times of crude drug total amount, boils rear slow fire and boils 10-20 minute, filter and remove residue, to obtain final product with big fire.
Instructions of taking: every twice-daily is taken sooner or later, each 30 milliliters, general 25-30 day and effective.
Medicine of the present invention also can be made into pill, powder or capsule.
In the present invention, effect of each crude drug is as follows:
Ramulus Cinnamomi: bitter in the mouth, cold in nature, nontoxic, GUIXIN warp, Liver Channel, lung meridian, stomach are through, tri-jiao channel.There is the effects such as pathogenic fire purging relieving restlessness, heat clearing away profit, removing pathogenic heat from blood and toxic substance from the body.
Radix Astragali Preparata: sweet in the mouth, slightly warm in nature, returns lung, spleen, liver, kidney channel.Have tonifying Qi and lifting yang, benefit defends consolidating superficial resistance, inducing diuresis to remove edema, holder skin ulcer granulation promoting.
Radix Angelicae Sinensis: sweet in the mouth, slightly warm in nature, returns lung, spleen, liver, kidney channel.There is enhancing human body immunity function, protect the liver, diuresis, defying age, anti-stress, blood pressure lowering, antibacterial action.
Radix Paeoniae Alba (parched): bitter in the mouth is sour, cool in nature to be slightly cold, and returns liver, spleen channel.There is the effects such as easing the affected liver of enriching blood, suppressing the hyperactive liver pain relieving, yin fluid astringing receipts antiperspirant.
Rhizoma Chuanxiong: bitter in the mouth, pungent, micro-Hui Tian, warm in nature, return liver, gallbladder, heart channel.There is blood-activating and qi-promoting, effect of wind-expelling pain-stopping.
Radix Rehmanniae Preparata: sweet in the mouth, slightly warm in nature.Return liver, kidney channel.There is YIN nourishing of enriching blood, life essence-filling, marrow-benefitting effect.
Radix Glycyrrhizae Preparata: process sweet, warm in nature, return spleen, stomach, lung meridian.There is benefiting qi and nourishing yin, the multiple arteries and veins that activates yang, cushion toxicity, strong effect.
Herba Lycopodii: bitter in the mouth, pungent, warm in nature, enters Liver Channel, has effect of expelling wind and cold, dehumidifying detumescence, relaxing muscles and tendons and activating QI and blood in the collateral.
Caulis Spatholobi: bitter in the mouth, micro-sweet, warm in nature, returns liver, the heart, kidney channel.There is relaxing muscles and tendons to promote blood circulation, effect of nourishing blood for regulating menstruation.
Radix Achyranthis Bidentatae: bitter in the mouth, acid, property are put down, and return liver, kidney channel.There is effect of kidney tonifying, essence replenishing, promoting blood circulation to restore menstrual flow, inducing diuresis for treating stranguria syndrome, heat-clearing and toxic substances removing.Can relaxing muscles and tendons to promote blood circulation.
10 kinds of natural Chinese medicine compatibilities chosen by the medicine that the present invention treats Raynaud disease, each crude drug synergism plays removing pathogenic heat from blood and toxic substance from the body, tonifying Qi and lifting yang, blood-activating and qi-promoting, benefiting qi and nourishing yin, activate yang the effects such as multiple arteries and veins, wind-expelling pain-stopping, life essence-filling, marrow-benefitting, relaxing muscles and tendons and activating QI and blood in the collateral, treating both the principal and the secondary aspects of a disease at the same time, effective to treatment Raynaud disease, have no side effect.And its preparation method is simple, the course for the treatment of is shorter, taking convenience, cost is low, and effective percentage reaches more than 90%.
Detailed description of the invention
Below in conjunction with embodiment, content of the present invention is further described, but is not limitation of the invention.
Embodiment 1:
Treat a medicine for Raynaud disease, the weight proportion of each raw material is:
Ramulus Cinnamomi 4 parts, Radix Astragali Preparata 8 parts, Radix Angelicae Sinensis 10 parts, Radix Paeoniae Alba (parched) 9 parts, Rhizoma Chuanxiong 4 parts, 8 parts, Radix Rehmanniae Preparata, Radix Glycyrrhizae Preparata 4 parts, Herba Lycopodii 9 parts, Caulis Spatholobi 15 parts, Radix Cyathulae 9 parts.Decoct into decoction oral according to a conventional method.
Embodiment 2:
Treat a medicine for Raynaud disease, the weight proportion of each raw material is:
Ramulus Cinnamomi 6 parts, Radix Astragali Preparata 10 parts, Radix Angelicae Sinensis 15 parts, Radix Paeoniae Alba (parched) 12 parts, Rhizoma Chuanxiong 6 parts, 10 parts, Radix Rehmanniae Preparata, Radix Glycyrrhizae Preparata 6 parts, Herba Lycopodii 12 parts, Caulis Spatholobi 20 parts, Radix Cyathulae 12 parts.Decoct into decoction oral according to a conventional method.
Embodiment 3:
Treat a medicine for Raynaud disease, the weight proportion of each raw material is:
Ramulus Cinnamomi 8 parts, Radix Astragali Preparata 12 parts, Radix Angelicae Sinensis 20 parts, Radix Paeoniae Alba (parched) 15 parts, Rhizoma Chuanxiong 8 parts, 12 parts, Radix Rehmanniae Preparata, Radix Glycyrrhizae Preparata 8 parts, Herba Lycopodii 15 parts, Caulis Spatholobi 25 parts, Radix Cyathulae 15 parts.Decoct into decoction oral according to a conventional method.
Experimental example:
In order to prove the clinical efficacy of medicine of the present invention further, selecting 30 routine patients, clinical observation is carried out to the curative effect of medicine of the present invention.
Efficacy determination based on transference cure, and changes situation with reference to effect etc., is divided into effective, effective and invalid.
Effective: symptom obviously alleviates and successful improves.
Effective: symptom and effect have certain improvement.
Invalid: symptom and sign are all without improvement or DeGrain.
Apply in 30 examples of Drug therapy Raynaud disease of the present invention, man 10 example, female 20 example.Fundamental symptoms is: Shou Zuleng, numb, and occasionally have pain, finger is sent out cool, symptom all has certain improvement after pale, blue, oral Drug therapy of the present invention, wherein effective 27 examples, effective 30 examples, invalid 0 is routine, effective percentage 100%.

Claims (2)

1. treat a medicine for Raynaud disease, it is characterized in that being made up of the raw material of following weight proportioning:
Ramulus Cinnamomi 4-8 part, Radix Astragali Preparata 8-12 part, Radix Angelicae Sinensis 10-20 part, Radix Paeoniae Alba (parched) 9-15 part, Rhizoma Chuanxiong 4-8 part, Radix Rehmanniae Preparata 8-12 part, Radix Glycyrrhizae Preparata 4-8 part, Herba Lycopodii 9-15 part, Caulis Spatholobi 15-25 part, Radix Cyathulae 9-15 part.
2. medicine according to claim 1, is characterized in that the weight proportion of each raw material is:
Ramulus Cinnamomi 6 parts, Radix Astragali Preparata 10 parts, Radix Angelicae Sinensis 15 parts, Radix Paeoniae Alba (parched) 12 parts, Rhizoma Chuanxiong 6 parts, 10 parts, Radix Rehmanniae Preparata, Radix Glycyrrhizae Preparata 6 parts, Herba Lycopodii 12 parts, Caulis Spatholobi 20 parts, Radix Cyathulae 12 parts.
CN201410431053.9A 2014-08-29 2014-08-29 Medicine for treating Raynaud disease Withdrawn CN105362452A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410431053.9A CN105362452A (en) 2014-08-29 2014-08-29 Medicine for treating Raynaud disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410431053.9A CN105362452A (en) 2014-08-29 2014-08-29 Medicine for treating Raynaud disease

Publications (1)

Publication Number Publication Date
CN105362452A true CN105362452A (en) 2016-03-02

Family

ID=55365403

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410431053.9A Withdrawn CN105362452A (en) 2014-08-29 2014-08-29 Medicine for treating Raynaud disease

Country Status (1)

Country Link
CN (1) CN105362452A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116870129A (en) * 2023-08-16 2023-10-13 安徽中医药大学第一附属医院(安徽省中医院) Compound traditional Chinese medicine for warming channel and dredging collaterals for treating reynolds phenomenon related to connective tissue diseases

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
耕耘等,: "《国家级名老中医验方大全》", 31 March 1999, 伊犁人民出版社 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116870129A (en) * 2023-08-16 2023-10-13 安徽中医药大学第一附属医院(安徽省中医院) Compound traditional Chinese medicine for warming channel and dredging collaterals for treating reynolds phenomenon related to connective tissue diseases
CN116870129B (en) * 2023-08-16 2024-03-26 安徽中医药大学第一附属医院(安徽省中医院) Compound traditional Chinese medicine for warming channel and dredging collaterals for treating reynolds phenomenon related to connective tissue diseases

Similar Documents

Publication Publication Date Title
CN102091234B (en) Traditional Chinese medicine composition for treating bone fracture diseases
CN104667244A (en) Foot bath composition for treating primary dysmenorrheal
CN104043087A (en) Traditional Chinese medicine composition for treating Raynaud syndrome
CN104013910A (en) Traditional Chinese medicine composition for treating hypertension
CN101269157B (en) Method for preparing wine for warming meridian, removing paralysism, releasing tendon, activating collaterals to relieve pain
CN104383515A (en) Chinese medicinal composition for treating postpartum rheumatism due to deficiency of qi and blood
CN104491778A (en) Pharmaceutical composition for treating alopecia areata
CN104173856A (en) Traditional Chinese medicine composition for treating morbid leukorrhea
CN104127567B (en) A kind of Chinese medicine composition for the treatment of diabetic peripheral neuropathy
CN105853591A (en) Cold-dispelling and moist-removing medicinal liquor
CN105012430A (en) Sciatica treating medicine and preparation method thereof
CN103623247A (en) Medicine for treating dizziness
CN105362452A (en) Medicine for treating Raynaud disease
CN104922627A (en) Decoction capable of treating Raynaud syndromes and preparation method for decoction
CN105477619A (en) Traditional Chinese medicine composition for treating delayed menorrhea
CN104606395A (en) Traditional Chinese medicine prescription treating menstrual fever
CN104784417A (en) Traditional Chinese medicine composition for curing impotentia
CN103877557B (en) A kind of Chinese medicine ointment and preparation method for the treatment of tinea unguium
CN103550437B (en) A kind of Chinese medicine composition for the treatment of the hepatic and renal YIN deficiency
CN104815314A (en) Medicine capable of effectively treating Raynaud's syndrome and preparation method thereof
CN105213985A (en) A kind of Chinese medicine decoction for the treatment of syndrome of marrow depletion due to kidney deficiency type cranial tinnitus
CN104857099A (en) Oral medicine for treating raynaud's syndrome and preparation method of oral medicine
CN104771605A (en) Traditional Chinese medicine composition for treating low back and leg pain
CN104001115A (en) Traditional Chinese medicine for treating hands and feet numbness
CN104435883A (en) Traditional Chinese medicine preparation for treating calcaneodynia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20160302